BIOQ (Bioqual) Other Current Receivables: $1.16 Mil (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOQ Bioqual Inc BIOQ
54 GF Score
Price $33.00
! 4 Warning Signs
View Full Analysis

What is Bioqual Other Current Receivables?

Bioqual BIOQ 54 Other Current Receivables is $1.16 Mil as of Nov. 2025. GuruFocus rates BIOQ with a GF Score™ of 54/100. The stock has 4 warning signs investors should review.

Bioqual's Other Current Receivables for the quarter that ended in Nov. 2025 was $1.16 Mil.

Bioqual's quarterly Other Current Receivables increased from Nov. 2024 ($0.00 Mil) to Aug. 2025 ($1.32 Mil) but then stayed the same from Aug. 2025 ($1.32 Mil) to Nov. 2025 ($1.16 Mil).

Bioqual's annual Other Current Receivables declined from May. 2011 ($2.79 Mil) to May. 2017 ($0.08 Mil) but then increased from May. 2017 ($0.08 Mil) to May. 2018 ($0.43 Mil).

Bioqual Other Current Receivables Related Terms

Bioqual Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Bioqual's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioqual Other Current Receivables Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.89 2.79 0.08 0.43

Bioqual Quarterly Data
Aug06 Nov06 Feb07 May07 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 May17 May18 Aug22 Aug23 Aug24 Nov24 Aug25 Nov25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 0.00 0.00 1.32 1.16
BIOQ
54GF Score
Bioqual Inc BIOQ
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioqual Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $1.16 Mil mean?
Bioqual (BIOQ) has a Other Current Receivables of $1.16 Mil as of Nov. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Bioqual and its competitors.
Is Bioqual's Other Current Receivables too high?
Bioqual's current Other Current Receivables is $1.16 Mil. Overall, Bioqual has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Bioqual's Other Current Receivables compare to ADVB and QUCY?
Bioqual's Other Current Receivables of $1.16 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Diagnostics & Research company?
A good Other Current Receivables depends on the Medical Diagnostics & Research industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Bioqual and its competitors. Bioqual's current Other Current Receivables is $1.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioqual stock overvalued right now?
Bioqual (BIOQ) has a current Other Current Receivables of $1.16 Mil. The current Other Current Receivables is $1.16 Mil. Bioqual's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Bioqual (BIOQ), the current Other Current Receivables is $1.16 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioqual Business Description

Address 9620 Medical Center Drive, Suite 310, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
54GF Score

Get the complete analysis for BIOQ

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.00
Price